Fibromuscular dysplasia (FMD), a disease that primarily affects young to middle-aged women, is characterized by the proliferation of connective tissue and muscle fibers within the arterial vessel walls.

Epidemiology


Etiology


Pathophysiology


Fibromuscular dysplasia (FMD) is an idiopathic, non-inflammatory, non-atherosclerotic, developmental condition that primarily affects small and medium-sized muscular arteries.

  • FMD results in ischemia by one or more of the following mechanisms:
    • Stenosis
    • Formation of saccular aneurysms → aneurysmal rupture
    • Arterial dissection → arterial occlusion
  • Renal artery stenosis → ↓ renal perfusion → compensatory activation of the renin–angiotensin–aldosterone system → secondary hypertension
  • Disease localization
    • Renal artery (renal FMD; ∼ 75–80% of cases)
    • Carotid and vertebral artery involvement (extracranial cerebrovascular FMD; ∼ 65–75% of cases and often bilateral)

Clinical features


  • Renal FMD
  • Cerebrovascular FMD
    • Headache, neck pain, pulsatile tinnitus
    • TIA, amaurosis fugax, stroke, Horner’s syndrome
    • Cervical bruit

Diagnostics


  • Best initial tests for renal FMD: duplex ultrasonography and/or CT angiography
    • Common finding: “string of beads” signPasted image 20240401113410.png
  • Differential diagnostics

Treatment